UBS ASSET MANAGEMENT AMERICAS LLC - ALDEYRA THERAPEUTICS INC ownership

ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 120 filers reported holding ALDEYRA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.51 and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of ALDEYRA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$74,89611,2120.00%
Other shareholders
ALDEYRA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 3,031,915$20,253,19221.02%
Perceptive Advisors 11,350,085$75,818,5682.53%
JOHNSON & JOHNSON 394,834$2,637,4910.97%
Joseph P. Lucia & Associates, LLC 28,331$189,2510.13%
WOODSTOCK CORP 137,179$916,3560.12%
Palo Alto Investors LP 160,800$1,074,1440.10%
Affinity Asset Advisors, LLC 44,348$296,2450.08%
Verition Fund Management LLC 935,273$6,247,6240.07%
FOX RUN MANAGEMENT, L.L.C. 33,519$223,9070.07%
TOBIAS FINANCIAL ADVISORS, INC. 34,173$228,2760.06%
View complete list of ALDEYRA THERAPEUTICS INC shareholders